Correlation of renal solute-free water reabsorption and energy of interaction of vasotocin analogs with V2 receptor

Biology Bulletin

Volumn 38, Issue 6, 2011, Pages 615-621

  Kutina, A V ^a   Karavashkina, T A ^a   Shakhmatova, E I ^a   Gao, J ^a   Mordvintsev, D Yu ^b   Kuzmin, D A ^b   Tsetlin, V I ^b   Natochin, Yu V ^a  

^a SECHENOV INSTITUTE OF EVOLUTIONARY PHYSIOLOGY AND BIOCHEMISTRY   (Russian Federation)

^b SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

RATTUS; RATTUS NORVEGICUS;

EID: 80855139119     PISSN: 10623590     EISSN: None     Source Type: Journal    
DOI: 10.1134/S1062359011060057     Document Type: Article

References (36)

1. 1a Type Receptors and Their Ligands, J. Biol. Chem., 2004, vol. 279, pp. 54445-54453.
2. Agre, P. and Homer, W., Smith Award Lecture. Aquaporin Water Channels in Kidney, J. Am. Soc. Nephrol., 2000, vol. 11, pp. 764-777.
3. Antunes-Rodrigues, J., de Castro, M., Elias, L. L., et al., Neuroendocrine Control of Body Fluid Metabolism, Physiol. Rev., 2004, vol. 84, p. 169-208.
4. 1a Receptor-Deficient Mice, Kidney Int., 2009, vol. 76, pp. 1035-1039.
5. 2 Receptor-Mediated Effects, Cardiovasc. Res., 2001, vol. 51, pp. 372-390.
6. Boone, M. and Deen, P. M., Physiology and Pathophysiology of the Vasopressin-Regulated Renal Water Reabsorption, Pfluders Arch., 2008, vol. 456, pp. 1005-1024.
7. Gimpl, G. and Fahrenholz, F., The Oxytocin Receptor System: Structure, Function, and Regulation, Physiol. Rev., 2001, vol. 81, pp. 629-683.
8. 1-Antagonists, Pflugers Arch., 1995, vol. 430, pp. 1004-1011.
9. 1 Vasopressin Receptors in the Rat Kidney Using Anti-Receptor Antibodies, Kidney Int., 1997, vol. 52, pp. 1206-1215.
10. Hausmann, H., Richters, A., Kreienkamp, H. J., et al., Mutational Analysis and Molecular Modeling of the Nonapeptide Hormone Binding Domains of the [Arg8]-Vasotocin Receptor, Proc. Natl. Acad. Sci. USA, 1996, vol. 93, pp. 6907-6912.
11. Hawtin, S. R., Simms, J., Conner, M., et al., Charged Extracellular Residues, Conserved Throughout a G-Protein-Coupled Receptor Family, are Required for Ligand Binding, Receptor Activation, and Cell-Surface Expression, J. Biol. Chem., 2006, vol. 281, pp. 38478-38488.
12. Karavashkina, T. A., Kutina, A. V., Shakhmatova, E. I., and Natochin, Yu. V., Mechanism of 1-Deamino-Arginine Vasotocin Induced Natriuresis in Rats, Gen. Comp. Endocrinol., 2011, vol. 170, pp. 460-467.
13. 3 Vasopressin Receptor and the Corticotroph Phenotype in Ectopic ACTH Syndrome, J. Clin. Invest., 1996, vol. 97, pp. 1311-1318.
14. Kowalczyk, W., Prahl, A., Derdowska, I., et al., Analogues of Neurohypophyseal Hormones, Oxytocin and Arginine Vasopressin, Conformationally Restricted in the N-Terminal Part of the Molecule, J. Med. Chem., 2006, vol. 49, pp. 2016-2021.
15. Kutina, A. V., Eliseev, I. I., Titov, M. I., et al., Selective effect of vasotocin analogues with amino acid substitutions in 4, 7, 8 positions on the water and cations excretion by the rat kidney, Ross. Fiziol. Zh. Im. I. M. Sechenova, 2009, vol. 95, no. 3, pp. 204-214.
16. 2 Receptor and Possible Link to Nephrogenic Diabetes Insipidus, Nature, 1992, vol. 357, pp. 336-339.
17. Mahlmann, S., Meyerhof, W., Hausmann, H., et al., Structure, Function, and Phylogeny of [Arg8]Vasotocin Receptors from Teleost Fish and Toad, Proc. Natl. Acad. Sci. USA, 1994, vol. 91, pp. 1342-1345.
18. Maybauer, M. O., Maybauer, D. M., Enkhbaatar, P., and Traber, D. L., Physiology of the Vasopressin Receptors, Best Pract. Res. Clin. Anaesthesiol., 2008, vol. 22, pp. 253-263.
19. 1a Arginine Vasopressin Receptor, Nature, 1992, vol. 356, pp. 523-526.
20. 1a Receptor. Evidence for a Major Localization Within Transmembrane Regions, J. Biol. Chem., 1995, vol. 270, pp. 25771-25777.
21. Natochin, Yu. V. and Shakhmatova, E. I., Vasopressin V1-Antagonist Increases the Hydroosmotic Response to Arginine Vasopressin in Frog Urinary Bladder, Pflugers Arch., 1992, vol. 421, pp. 406-408.
22. Natochin, Yu. V., Pochka (A Kidney), St. Petersburg: Izd. SPbGU, 1997, 208 p.
23. Natochin, Yu. V., Vasopressin: Activity Mechanism and Clinical Physiology, Probl. Endokrinol., 2003, vol. 49, no. 2, pp. 43-50.
24. Nielsen, S., Frokiaer, J., Marples, D., et al., Aquaporins in the Kidney: from Molecules to Medicine, Physiol. Rev., 2002, vol. 82, pp. 205-244.
25. Phalipou, S., Seyer, R., Cotte, N., et al., Docking of Linear Peptide Antagonists into the Human V(1a) Vasopressin Receptor. Identification of Binding Domains by Photoaffinity Labeling, J. Biol. Chem., 1999, vol. 274, pp. 23316-23327.
26. Podstawka, E., Sikorska, E., Proniewicz, L. M., and Lammek, B., Raman and Surface-Enhanced Raman Spectroscopy Investigation of Vasopressin Analogues Containing 1-Aminocyclohexane-1-Carboxylic Acid Residue, Biopolymers, 2006, vol. 83, pp. 193-203.
27. 1b Vasopressin Receptors, Mol. Endocrinol., 2007, vol. 21, pp. 512-523.
28. Slusarz, M. J., Sikorska, E., Slusarz, R., and Ciarkowski, J., Molecular Docking-Based Study of Vasopressin Analogues Modified at Positions 2 and 3 with N-Methylphenylalanine: Influence on Receptor-Bound Conformations and Interactions with Vasopressin and Oxytocin Receptors, J. Med. Chem., 2006, vol. 49, pp. 2463-2469.
29. Sobolewski, D., Prahl, A., Derdowska, I., et al., Influence of Conformationally Constrained Amino Acids Replacing Positions 2 and 3 of Arginine Vasopressin (AVP) and Its Analogues on Their Pharmacological Properties, Protein Pept. Lett., 2007, vol. 14, pp. 213-217.
30. Sugimoto, T., Saito, M., Mochizuki, S., et al., Molecular Cloning and Functional Expression of a cDNA Encoding the Human V1b Vasopressin Receptor, J. Biol. Chem., 1994, vol. 269, pp. 27088-27092.
31. 1a Vasopressin Receptor Using Sulfydryl-Reactive Ligands and Cysteine Mutants as Chemical Sensors, J. Biol. Chem., 2003, vol. 278, pp. 40010-40019.
32. Thibonnier, M., Coles, P., Conarty, D. M., et al., A Molecular Model of Agonist and Nonpeptide Antagonist Binding to the Human V(1) Vascular Vasopressin Receptor, J. Pharmacol. Exp. Ther., 2000, vol. 294, pp. 195-203.
33. van Kesteren, R. E. and Geraerts, W. P., Molecular Evolution of Ligand-Binding Specificity in the Vasopressin/Oxytocin Receptor Family, Ann. N. Y. Acad. Sci., 1998, vol. 839, pp. 25-34.
34. van Kesteren, R. E., Tensen, C. P., Smit, A. B., et al., Co-Evolution of Ligand-Receptor Pairs in the Vasopressin/Oxytocin Superfamily of Bioactive Peptides, J. Biol. Chem., 1996, vol. 271, pp. 3619-3626.
35. Warne, J. M., Harding, K. E., and Balment, R. J., Neurohypophysial Hormones and Renal Function in Fish and Mammals, Comp. Biochem. Physiol. B. Biochem. Mol. Biol., 2002, vol. 132, pp. 231-237.
36. Wheatley, M., Howl, J., Morel, A., and Davies, A. R., Homology Between Neurohypophyseal Hormone Receptors, Biochem. J., 1993, vol. 296, p. 519.